|
+ |
|
→ |
|
+ | UDP |
|
+ |
|
→ |
|
+ | UDP |
* Produces type 1 chain linkage in glycolipids and core-3 O-glycans, but not N-linked glycoproteins.
* May be an important enzyme forming CA19-9 in colon cancer. Beyond serving as a biomarker, CA19-9 also promotes pancreatitis and pancreatic cancer (in mice).
* B3GalT5 efficiently transfers Gal to the GlcNAc of the glycolipid Lc3Cer and to the terminal GalNAc residue of the globoside Gb4.
* It may thus contribute to the formation of CA 19-9, SSEA-3 and elongated core-3 O-glycans.
* Expression is restricted to the colorectum, small intestine, stomach, and pancreas.
ER | Cis- | Medial- | Trans- | TGN |
---|---|---|---|---|
B3GALT5/hsa-miR-4777-3p |
---|
miRNA Target | Site Type | Pos. | Context Score | Frac. | Wt. Context | Frac. | Conserved | Quality |
---|---|---|---|---|---|---|---|---|
5'...UGUGAAAAUCUGAA
UGAGGUAA
... 3' AUGUCGUAAGAUCU ACUCCAU A |
8mer | 7727-7734 | -0.289 | 93.0 | -0.289 | 95.0 | noncon | |
5'...CCUGGGUCCCCGAA
GAGGUAA
G... 3' AUGUCGUAAGAUCUA CUCCAU A |
7mer-A1 | 10752-10758 | -0.209 | 82.0 | -0.209 | 89.0 | noncon | |
5'...ACCCACCCGGUAAG
GAGGUAA
C... 3' AUGUCGUAAGAUCUA CUCCAU A |
7mer-A1 | 6200-6206 | -0.137 | 65.0 | -0.137 | 80.0 | noncon |